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pAbstract
Background: Sepsis is characterised by diminished vasopressor responsiveness.
Vasoconstriction depends upon a balance: Ca2+-dependent myosin light-chain kinase
promotes and Ca2+-independent myosin light-chain phosphatase (MLCP) opposes
vascular smooth muscle contraction. The enzyme Rho kinase (ROK) inhibits MLCP,
favouring vasoconstriction. We tested the hypothesis that ROK-dependent MLCP
inhibition was attenuated in late sepsis and associated with reduced contractile
responses to certain vasopressor agents.
Methods: This is a prospective, controlled animal study. Sixteen-week-old C57/BL6
mice received laparotomy or laparotomy with caecal ligation and puncture (CLP).
Antibiotics, fluids and analgesia were provided before sacrifice on day 5.
Vasoconstriction of the femoral arteries to a range of stimuli was assessed using
myography: (i) depolarisation with 87 mM K+ assessed voltage-gated Ca2+ channels
(L-type, Cav1.2 Ca
2+ channels (LTCC)), (ii) thromboxane A2 receptor activation assessed
the activation state of the LTCC and ROK/MLCP axis, (iii) direct PKC activation
(phorbol-dibutyrate (PDBu), 5 μM) assessed the PKC/CPI-17 axis independent of Ca2+
entry and (iv) α1-adrenoceptor stimulation with phenylephrine (10−8 to 10−4 M) and
noradrenaline (10−8 to 10−4 M) assessed the sum of these pathways plus the role of the
sarcoplasmic reticulum (SR). ROK-dependent MLCP activity was indexed by Western
blot analysis of P[Thr855]MYPT. Parametric and non-parametric data were analysed
using unpaired Student's t-tests and Mann-Whitney tests, respectively.
Results: ROK-dependent inhibition of MLCP activity was attenuated in both
unstimulated (n = 6 to 7) and stimulated (n = 8 to 12) vessels from mice that had
undergone CLP (p < 0.05). Vessels from CLP mice demonstrated reduced
vasoconstriction to K+, thromboxane A2 receptor activation and PKC activation
(n = 8 to 13; p < 0.05). α1-adrenergic responses were unchanged (n = 7 to 12).
Conclusions: In a murine model of sepsis, ROK-dependent inhibition of MLCP
activity in vessels from septic mice was reduced. Responses to K+ depolarisation,
thromboxane A2 receptor activation and PKC activation were diminished in vitro
whilst α1-adrenergic responses remained intact. Inhibiting MLCP may present a
novel therapeutic target to manage sepsis-induced vascular dysfunction.
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Septic shock arises when infection causes direct tissue injury and a maladaptive host re-
sponse culminating in refractory vasodilation and loss of vasopressor sensitivity. Clinic-
ally, this manifests as septic shock and multi-organ failure, which even in modern
intensive care units heralds a 90-day mortality rate of over 30% [1,2].
Vascular smooth muscle (VSM) contraction is determined by the balance of two op-
posing enzymatic processes: (i) myosin light-chain kinase (MLCK) phosphorylation of
myosin enables actin-myosin cross bridge cycling and contraction; (ii) myosin light-
chain phosphatase (MLCP) dephosphorylation of myosin uncouples actin-myosin,
favouring relaxation. Activation of MLCK depends on cytosolic calcium (Ca2+) binding
to calmodulin. Cystosolic Ca2+ is derived from either the sarcoplasmic reticulum (SR)
or the extracellular space through, for example, voltage-gated L-type Cav1.2 Ca
2+ chan-
nels (LTCC). Vasoconstrictors variably modulate the cytosolic [Ca2+] and the degree of
inhibition of MLCP to regulate vascular tone. MLCP can be inhibited either by (i)
RhoA activation of Rho kinase (ROK), which inhibits MLCP by phosphorylating
Thr855 of the MYPT regulatory subunit of MLCP [3-5], or (ii) PKC-mediated phos-
phorylation of Thr38 CPI-17, which directly inhibits MLCP [6-8]. Inhibiting MLCP
promotes VSM contraction independent of the prevailing intracellular [Ca2+] - ‘Ca2+
sensitisation’. On the other hand, increasing MLCP activity by reducing Thr855 phos-
phorylation of MYPT or reduced Thr38 CPI-17 phosphorylation shifts the [Ca2+]:force
relationship to the right - effectively reducing Ca2+ sensitivity. Individual vasopressors
vasoconstrict through different signalling pathways; for instance, thromboxane is bi-
modal, activating LTCC and RhoA/ROK [3], whilst α1-adrenergic receptor agonists are
multimodal, inducing vasoconstriction through two sources of Ca2+ (SR and LTCC)
and two MLCP inhibitory pathways (RhoA/ROK and PKC/CPI-17) [9]. A figure sum-
marising these contractile signalling pathways is provided (Figure 1).
There is evidence that Ca2+ desensitisation contributes to septic shock: in a rat
model, acute endotoxaemia was associated with augmented MLCP activity and reduced
sensitivity to an α1-adrenergic agonist [10]. Other models of sepsis have identified a
rightward shift in the cytosolic [Ca2+]: force relationship [11] and attenuated vasopres-
sor responses despite the presence of augmented cytosolic [Ca2+] [12], suggesting in-
creased activity of MLCP. Many investigations into the vascular pathology of septic
shock have focused on the early, hyperdynamic phase of sepsis. Importantly, however,
70% of deaths from sepsis occur after the first 3 days [2,13,14]. Mechanisms of vascular
dysfunction at this later stage of disease remain relatively unexplored, but important
differences have been identified; specifically, whilst early sepsis is associated with im-
paired vascular responses to α1-adrenergic agonists in vitro and a reduction in cytosolic
Ca2+ entry, in the later phases of sepsis, the in vitro response to α1-adrenergic agonists
and Ca2+ flux are restored [15,16], as is the in vivo blood pressure response to moder-
ate doses of phenylephrine [17]. However, sensitivity to local vasoconstriction by
thromboxane A2 (TxA2) and direct electrical coupling of the VSM membrane, signifi-
cant for their importance in regulating regional blood flow [18], has not been evaluated
in sepsis. Unlike α1-adrenergic agonists, TxA2 and membrane depolarisation do not
stimulate SR Ca2+ release or PKC/CPI-17-mediated inhibition of MLCP and are there-
fore potentially more vulnerable to attenuation of the RhoA/ROK pathway [3,19].
Diminished efficacy of endogenous TxA2 and direct depolarisation secondary to
Figure 1 Smooth muscle cell contraction depends on Ca2+-dependent and Ca2+-independent
pathways. Actin-myosin cross bridge cycling and smooth muscle contraction depend on phosphorylation
of the myosin light chain by Ca2+: calmodulin (CaM)-dependent myosin light-chain kinase (MLCK). Relaxation is
favoured by myosin light-chain phosphatase (MLCP) as the active subunit removes the phosphoryl group from
the myosin light chain. Cytosolic [Ca2+] is derived from (i) the extracellular space (through voltage-operated
Ca2+ channels (VOCC; predominantly Cav1.2 L-type Ca
2+ channels) and receptor-operated non-specific cation
channels (ROCC)) or (ii) IP3-dependent release from the sarcoplasmic reticulum (SR). MLCP is inhibited, favouring
contraction, either through (i) direct inhibition by PKC-dependent CPI-17 or (ii) inhibitory phosphorylation of
the regulatory subunit MYPT by RhoA-dependent Rho kinase. α1-adrenergic G protein-coupled receptors (GPCR)
activate all four contractile pathways: VOCC/ROCC, IP3/SR, PKC/CPI-17 and RhoA/ROK; TxA2 GPCR activate VOCC
and RhoA/ROK; PDBu activates PKC/CPI-17 whilst high-[K+]-mediated depolarisation activates VOCC. PLC,
phospholipase C; PIP2, phosphatidylinositol 4,5-bisphosphate; DAG, diacylglycerol; IP3, inositol triphosphate.
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tic shock and dysregulation of regional blood flow [18,20].
To address this gap in knowledge, we used a murine caecal ligation and puncture
(CLP) model of sepsis that included an intensive care treatment regimen that simulated
the clinical experience of a septic patient [21,22]. CLP is a well-described, reproducible
model of sepsis incorporating polymicrobial infection and tissue necrosis [23,24]. As an
animal model, it replicates many of the physiological, haemodynamic and metabolic se-
quelae of sepsis [25-28]. We used a 5-day model of sepsis to identify mechanisms that
contribute to vasopressor insensitivity during the late stages of sepsis, noting that most
deaths from sepsis occur after the first 3 days [2,13,14]. We hypothesised that CLP sepsis
would be associated with increased MLCP activity and Ca2+ desensitisation and that this
activity would be associated with a reduction in in vitro vascular responses to vasocon-
strictors such as thromboxane A2, phorbol ester and high K
+ which are uni- or bimodal,
engaging one or two signalling pathways. We hypothesised that responses to α1-adrener-
gic agonists which invoke multimodal mechanisms of Ca2+ entry (LTCC and SR Ca2+)
and Ca2+ sensitisation (PKC/CPI-17 and Rho/ROK) would be relatively preserved in vitro.
Methods
Mice
All animal procedures were approved by the Animal Ethics Committees of the Institute of
Medical and Veterinary Science (IMVS; Adelaide, South Australia) and the University of
Reddi et al. Intensive Care Medicine Experimental  (2015) 3:2 Page 4 of 15Adelaide (Adelaide, South Australia). Twenty-six, 16-week-old, male C57/BL6 mice
purchased from the Animal Resources Centre, WA, were housed in the IMVS Animal
Care Facility in individual cages following surgery with food and water ad libitum.
Changes in clinical status were determined by cumulative clinical record scores as
outlined previously [25].Caecal ligation and puncture
Sixteen mice underwent a midline laparotomy under general anaesthetic (1% to 1.5%
isoflurane in oxygen) followed by location and ligation of the caecum 5 mm from the
ileocaecal valve. A 21-gauge needle was used to puncture the caecum midway between
the ligature and the tip of the caecum. Faecal material was expressed from the caecum
into the abdominal cavity through the puncture site before the perforated caecum was
placed back into the abdominal cavity and the incision was sutured. Morbidity associ-
ated with CLP surgery was assessed by monitoring for weight loss, abnormal tempera-
tures (normal core temperature range 34 to 37) and other morbidity indicators
including ruffled coat, hunched posture, reduced mobility, diarrhoea, abdominal disten-
tion, loss of righting ability and laboured respiration; these parameters were scored to
calculate a cumulative disease index [25]. Post-mortem was carried out on representa-
tive CLP mice demonstrating acute suppurative and necrotising peritonitis. Ten mice
underwent laparotomy without CLP as sham controls. All mice underwent an intensive
care regime post-surgery: twice-daily subcutaneous administration of antibiotic (Baytril
(enrofloxacin), 0.03 mg kg−1, 50 μl), fluid (saline 1 ml) for 5 days and analgesia (butorphanol,
0.05 mg kg−1, 25 μl) for 2 days. On day 5, surviving mice were killed with pentobarbitone
(60 mg kg−1 i.p.) before tissue collection.Isolation of vessels
Femoral and caudal arteries were placed in cold Ca2+-free normal HEPES-Tyrode buffer
containing, in mM, 135.5 NaCl, 5.9 KCl, 1.2 MgCl2, 11.6 glucose and 11.6 HEPES, pH 7.4,
dissected free of adventitia and cut into 2-mm segments; femoral and caudal arteries
were 250 and 300 μm in diameter, respectively. Caudal artery segments from sham and
CLP treatment groups were snap-frozen in liquid nitrogen and stored at −80°C prior
to SDS-PAGE/Western blot analysis.Vascular myography
Femoral arterial segments from sham and CLP treatment groups were mounted on a
DMT 610M wire myograph (DMT, Aarhus, Denmark) to quantify isometric tension
following stimulation. Following length tension analysis, femoral arteries were set at an
optimal resting tension of 3 mN and equilibrated in normal HEPES-Tyrode buffer (in
mM, 135.5 NaCl, 5.9 KCl, 1.2 MgCl2, 2.5 CaCl2, 11.6 glucose, 11.6 HEPES, pH 7.4).
The arteries were equilibrated for 30 min before being stimulated three times with a
depolarising stimulus of 87 mM K+-HEPES-Tyrode buffer (K+HT), in which NaCl
was substituted with KCl to maintain an iso-osmolar solution. Following relaxation in
NHT buffer, the arteries were incubated with the stable thromboxane A2 receptor
agonist U46619 (0.1 μM), the direct PKC activator phorbol-dibutyrate (PDBu) (5 μM),
the α1-adrenergic agonist phenylephrine (PE) (10
−8 to 10−4 M) or noradrenaline (NA)
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agonist action. Noradrenaline was used because, although less specific in action than
phenylephrine, it is more commonly used both in sepsis research and clinical
practice.
Following a 10-min stimulation with U46619 (0.1 μM) or PDBu (5 μM) or generation
of a dose-response relationship with NA or PE (10−8 to 10−4 M), tissues were snap-frozen
in dry ice-cold 10% trichloroacetic acid/acetone, washed with dry ice-cold acetone and
stored at −80°C prior to SDS-PAGE/Western blot analysis.
Myography data and biochemical analysis of stimulated arterial tissue was derived
from the femoral artery. As quantities of the femoral artery were limited, biochemical
analysis of unstimulated sham and CLP tissue was derived from the caudal artery
(nb caudal segments were always compared with caudal and femoral with femoral).
Endothelial integrity of arterial segments was confirmed by phenylephrine challenge
followed by an intact 90% ACh relaxation.Western blot analysis of MYPT
For analysis of total MYPT and P[Thr855]MYPT, proteins were extracted from each
2-mm arterial segment using 100 μl of sample buffer containing 50 mM Tris-HCl, pH
6.8, 1% (w/v) SDS, 1× Complete™ protease inhibitor cocktail (Roche, Mannheim,
Germany), 100 μM di-isopropylfluorophosphate (Sigma-Aldrich, Caste Hill, Australia),
10 mM DTT, 10% (w/v) sucrose and 0.1% (w/v) bromophenol blue. Samples were
heated to 95°C for 5 min and then agitated for 30 min prior to SDS-PAGE using a
Bio-Rad (Sydney, Australia) Mini-PROTEAN II unit at 200 V for 60 min. For analysis of
MYPT, proteins were transferred, using a Bio-Rad Mini transfer unit, onto 0.22 μm
nitrocellulose (Bio-Rad) at 100 V for 30 min in transfer buffer containing 25 mM
Tris-HCl, 192 mM glycine, 0.1% (w/v) SDS and 20% (v/v) methanol.
Following protein transfer to nitrocellulose, non-specific binding sites were blocked
with 50% LI-COR Odyssey blocking buffer (LI-COR Biosciences, Lincoln, NE, USA) for
60 min, followed by incubation with TBS-T (20 mM Tris, 150 mM NaCl, 0.05% (v/v)
Tween-20) containing either a mouse-derived affinity-purified anti-MYPT antibody
(1:1,000) made in-house or a commercially available (Upstate Biotechnology, Lake
Placid, NY, USA) rabbit-derived anti-P[Thr855]MYPT antibody (1:1,000) for 60 min.
Nitrocellulose membranes were washed three times in TBS-T and incubated with a
1:10,000 dilution (in TBS-T) of biotin-conjugated secondary antibodies (Pierce Thermo
Scientific, Rockford, IL, USA): anti-mouse IgG for MYPT and anti-rabbit IgG for P
[Thr855]MYPT (1:10,000), for 60 min before another three washes with TBS-T. The
nitrocellulose was then incubated for 60 min in TBS-T with a 1:10,000 dilution of
streptavidin conjugated to the 800-nm DyLight fluorochome (Pierce Thermo Scientific);
fluorescence was detected and quantified using the LI-COR Odyssey system. Western
blot signals of the Thr855 phosphorylation state of MYPT of untreated vs. U46619
(0.1 μM)- or PDBu (5 μM)-treated rat caudal artery as previously published [3] were
used as controls.
Although consistency of protein content was confirmed with Coomassie blue-stained
actin, all Western blot signals were evaluated and found to be within the linear range
of detection. Vessel size and protein load were not significantly different; nevertheless,
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MYPT to total MYPT taken from the same sample.Statistical analysis
The Mann-Whitney test was used for non-parametric data comparisons, and Student's
t-test was used to compare parametric data (both two-tailed); p < 0.05 was considered
statistically significant. Asterisks indicate statistically significant differences from con-
trol; data are presented as mean ± SEM.Results
Morbidity and mortality
There were no deaths in sham-operated mice. The mortality rate in CLP-operated
mice was 16%, similar to the real-world experience of severe sepsis managed in a
critical care environment [29,30]. The cumulative disease index was significantly
higher for mice undergoing CLP surgery than for sham-operated controls (p < 0.05,
data not shown) [25].Does the ROK-dependent basal activity state of myosin phosphatase, indexed by Thr855
MYPT phosphorylation, differ between septic and control mice?
To compare the basal activity state of MLCP in sham and CLP mice, the proportion of
total MYPT in the [Thr855]-phosphorylated, i.e. ROK-inhibited, state was identified
using Western blot analysis of unstimulated mouse caudal artery segments. The pro-
portion of [Thr855]-phosphorylated MYPT in unstimulated vessels was greater in sham
than in CLP mice (n = 6 to 7; p < 0.05), indicating that MLCP was more active in CLP
mice favouring vasorelaxation (Figure 2).Figure 2 Sepsis was associated with increased activation state of MLCP. The activity state of MLCP
was greater in isolated, unstimulated caudal arteries from 5-day CLP mice than in those from sham mice.
The increased activity state of MLCP was indexed by reduction in the ratio of Thr855 phosphorylated to
unphosphorylated MYPT determined by Western blot analysis of snap-frozen vessel segments. *p < 0.05,
n = 6 to 7.
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and sham mice?
Thromboxane activates the RhoA/ROK pathway leading to inhibitory phosphorylation
of Thr855 MYPT, the regulatory subunit of MLCP, favouring contraction by Ca2+ sensi-
tisation [3]. To establish whether the ability of the TxA2 receptor to inhibit MLCP was
attenuated in CLP compared to sham mice, the [Thr855] phosphorylation state of
MYPT was compared in isolated femoral artery segments following challenge with the
TxA2 receptor agonist U46619 (0.1 μM). CLP mice showed reduced phosphorylation of
[Thr855]MYPT (less MLCP inhibition) in response to TxA2 receptor stimulation than
sham-treated mice (Figure 3; n = 9 to 12; p < 0.05).Was the reduction in Thr855 MLCP phosphorylation in CLP mice associated with a
reduction in vascular contractility?
TxA2 elicits VSM contraction both through Rho kinase-mediated MLCP inhibition
and by increasing the open probability of LTCC. If RhoA/ROK activity was disrupted
during sepsis, decreasing [Thr855]MYPT phosphorylation, it would be expected that
activation of TxA2 receptors would fail to fully restore MLCP inhibition. The conse-
quence would be reduced Ca2+ sensitivity and a diminished contractile response to
the TxA2 mimetic U46619. The contraction of isolated femoral artery segments in re-
sponse to U46619 (0.1 μM) was attenuated in CLP compared to sham mice (Figure 4;
n = 10 to 12; p < 0.05), consistent with the hypothesis that reduced MLCP inhibition
contributes to septic shock.Was the contractile response to PDBu, a direct activator of PKC/CPI-17, attenuated in
sepsis?
The direct PKC agonist PDBu inhibits MLCP by stimulating PKC-dependent phosphor-
ylation of Thr38 of CPI-17 [31]. In the Thr38-phosphorylated state, CPI-17 is a specific,
direct inhibitor of MLCP [6]. Contractile responses to PDBu (5 μM) were reduced inFigure 3 TxA2 receptor-mediated inhibition of MLCP was attenuated in sepsis. The activity state of
MLCP was increased in femoral arteries stimulated with U46619 (0.1 μM) in 5-day CLP mice relative to those
in sham mice (indexed by reduction in the ratio of Thr855 phosphorylated to unphosphorylated MYPT on
Western blot analysis). *p < 0.05, n = 9 to 12.
Figure 4 The vascular contractile response to the thromboxane receptor agonist U46619 was
attenuated in sepsis. Wire myograph-mounted femoral arteries from 5-day CLP mice developed lower
tension under stimulation with U46619 (0.1 μM) compared to those from sham mice. *p < 0.05, n = 10 to 12.
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(Figure 5; n = 8; p < 0.05). As expected, treatment of artery segments from control mice
with PDBu did not directly alter the Thr855 phosphorylation of MYPT (data not
shown) [19]. To identify whether the attenuated contractile response to PDBu in CLP
mice may have resulted from a sepsis-dependent reduction in baseline Thr855 phos-
phorylation of MYPT and consequently augmented MLCP activity, we used Western
blot analysis to ascertain the Thr855 phosphorylation state of MYPT in control and
CLP mice. We identified a reduction in Thr855 phosphorylation of MYPT in the PDBu
(5 μM)-treated femoral artery segments from CLP mice compared to segments from
sham mice (Figure 6; n = 8; p < 0.05).Could the attenuated contractile response to TxA2 receptor and PKC/CPI-17 stimulation
in CLP mice be wholly explained by changes in membrane potential during sepsis?
A significant body of work has demonstrated that augmented ATP-sensitive potassium
(KATP) channel function causes VSM hyperpolarisation with consequent vasodilationFigure 5 The vascular contractile response to the direct PKC activator phorbol-dibutyrate (PDBu)
was attenuated in sepsis. Wire myograph-mounted femoral arteries from 5-day CLP mice developed lower
tension under stimulation with PDBu (5 μM) compared to those from sham mice. *p < 0.05, n = 8 to 13.
Figure 6 Attenuated PKC-dependent contraction in septic mouse artery was associated with
reduced inhibitory phosphorylation of MLCP. The activity state of MLCP was increased in femoral
arteries stimulated with PDBu (5 μM) in 5-day CLP mice relative to those in sham mice (indexed by reduction in
the ratio of Thr855 phosphorylated to unphosphorylated MYPT on Western blot analysis). *p < 0.05, n = 8.
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CPI-17 depend on both the basal activity of MLCP and baseline conductance of the
KATP channel as it modulates membrane potential and hence the activity of LTCC. In
order to isolate the contributions made by increased MLCP and KATP channel activities
to attenuated functional vascular contractile responses, we made use of a high-K+
depolarising solution, which directly activates LTCC independent of KATP channel con-
ductance. The contractile response to high-K+-mediated depolarisation of isolated fem-
oral artery segments from CLP mice was reduced compared to those from sham mice
independent of KATP activity (Figure 7; n = 9 to 13; p < 0.05).Is the contractile response to α1-adrenergic stimulation intact during the later phase of sepsis?
VSM stimulation by α1-adrenergic agonists involves Ca
2+ entry through LTCC and
from SR as well as Ca2+ sensitisation mediated by both PKC/CPI-17 and RhoA/ROKFigure 7 The vascular contractile response to depolarisation with high-K+ HT solution was attenuated
in sepsis. Wire myograph-mounted femoral arteries from 5-day CLP mice developed lower tension under
stimulation with a depolarising high-K+ HT solution compared to those from sham mice. *p < 0.05, n = 9 to 13.
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longer periods of sepsis have found recovery of contractile responses to α1-adrenergic
stimulation [16]. We used isolated femoral vessels from a 5-day model of polymicrobial
sepsis, somewhat akin to a clinical scenario, to identify whether survivors had recovered
α1-adrenergic response. Figure 8 shows that the contractile response to the α1-adrenergic
agonists noradrenaline (Figure 8A) and phenylephrine (Figure 8B) (10−8 to 10−4 M)
was not significantly different in CLP compared to sham mice (Emax and EC50 p = NS,
n = 7 to 12).Discussion
Hospital mortality from septic shock remains around 30%, highlighting the need for
a more complete understanding of the mechanisms of pathological vasodilation [1].
Proposed mechanisms include reduced α1-receptor density and reduced α1-adrener-
gic signal transduction [34], activation of vascular KATP channels [33], impaired SR
Ca2+ release [15,35], relative corticosteroid and vasopressin deficiency [36,37] and
activation of inducible nitric oxide synthase [38] and vasodilating inflammatory me-
diators [39-42]. We tested the hypothesis that reduced inhibition of MLCP promotes
Ca2+ desensitisation, contributing to pathological vasodilation in a murine CLP
model of sepsis. Normally, MLCP inhibition sensitises the vascular contractile appar-
atus to Ca2+, favouring vasoconstriction [19,43]. Events that release MLCP inhibition
by reducing either (i) RhoA/ROK-mediated inhibitory Thr855 phosphorylation of
the regulatory subunit MYPT or (ii) PKC-mediated Thr38 phosphorylation of CPI-
17 favour vasorelaxation [19]. Using a 5-day murine model of polymicrobial sepsis,
we identified that both the baseline phosphorylation state of Thr855 MYPT and the
Thr855 phosphorylation state of MYPT following stimulation with the TxA2 receptor
agonist U46619 (0.1 μM) were attenuated in septic animals compared to sham-operated
controls (Figures 2 and 3). Reduced Thr855 MYPT phosphorylation was associated with
reduced vasoconstrictor response to U46619, PDBu or high-[K+]-mediated depolarisation
(Figures 4, 5 and 7). These data are consistent with late sepsis being associated with Ca2+Figure 8 Vasoconstrictor responses to stimulation with phenylephrine and noradrenaline remained
intact in arteries from septic mice. Dose-response curves to stimulation with NA (10−8 to 10−4 M) (A) and
PE (10−8 to 10−4 M) (B) were generated using wire myograph-mounted femoral arteries. For both agonists,
dose-response curves in 5-day CLP mice (filled circles) and sham mice (hollow circles) did not differ with
regard to EC50 or Emax (p > 0.05). (n = 7 to 12).
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vasopressors.
Previous data are consistent with the view that vasopressor responses can be attenuated
in sepsis due to Ca2+ desensitisation, rather than as a consequence of reduced flux of
Ca2+ into the cytosol [Ca2+]cyt. For example, the [Ca
2+]cyt content in the aortae of rats
with confirmed CLP sepsis was actually elevated relative to that of non-septic animals
[12]. Isolated mesenteric arteries from rats injected with Escherichia coli lipopolysacchar-
ide (LPS) also had elevated VSM [Ca2+]cyt and a force:intracellular Ca
2+ relationship
shifted to the right, consistent with Ca2+ desensitisation [11]. More recently, in an
acute (6 to 24 h) rat model of LPS-induced endotoxaemia, da Silva-Santos and col-
leagues identified reduced inhibitory phosphorylation of MLCP in the mesenteric
vasculature, associated with reduced vasopressor sensitivity [10].
Sepsis in humans typically lasts longer than most experimental animal models of sep-
sis, which, for practical reasons, are often less than 24 h. In clinical practice, most
deaths occur after several days of sepsis [2,13,14]. It is arguable that a CLP model,
whereby tissue necrosis and polymicrobial infection with host enteric organisms de-
velop over several days after traumatic perforation of a viscus, reflects a more common
clinical paradigm than sepsis induced by injection of bacterial inoculum or LPS [44,45].
We evaluated the functional and molecular features of murine vascular dysfunction
5-days post caecal ligation and puncture.
Our data identified an important difference in vascular response between acute endo-
toxaemia and a 5-day peritonitis model: the first 2 to 6 h of acute endotoxaemia models
typically demonstrate reduced vasoconstriction in response to α1-adrenoceptor stimula-
tion [10,16,33,46]. In contrast, after 5 days of polymicrobial sepsis, we identified normal
in vitro α1-adrenoceptor-mediated vasoconstriction, consistent with endotoxaemia
models, which found recovery of in vitro and in vivo sensitivity to moderate doses of
α1-adrenoceptor agonist between 6 and 24 h [16,17]. However, our data identifies clear
insensitivity to other vasoconstrictor mechanisms, including TxA2 receptor activation
and direct membrane depolarisation (Figures 4, 5 and 7). α1-adrenoceptor agonist re-
sponses may demonstrate resilience by recruiting multiple, parallel signalling pathways
to achieve contraction (Figure 1), specifically 1) LTCC opening, 2) SR Ca2+ release, 3)
inhibition of MLCP by PKC/CPI-17 and 4) inhibition of MLCP by RhoA/ROK phos-
phorylation of MYPT. In particular, α1-adrenoceptor agonists increase cytosolic
[Ca2+]cyt through SR Ca
2+ release, a mechanism not shared by TxA2 receptor, PDBu
activation or high-K+-mediated contraction [3,19], and have two mechanisms by which
to inhibit MLCP through both PKC/CPI-17 and RhoA/ROK. These data provide a
mechanistic explanation for the effectiveness of α1-adrenoceptor agonists as vaso-
constrictors in sepsis.
The results of our study together with those of da Silva-Santos and colleagues [10]
indicate two salient findings: 1) disinhibition of MLCP favouring Ca2+ desensitisation
has been identified at different time points and in different models of sepsis, suggesting a
potentially important role in the pathogenesis of septic shock, and 2) preservation of
in vitro α1-adrenoceptor agonist sensitivity may not necessarily reflect intact vasocon-
strictor responses to other physiologically significant stimuli.
Several potential mechanisms by which sepsis might promote MLCP disinhibition
and Ca2+ desensitisation can be postulated. Pathogenic bacteria produce toxins capable
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disinhibiting MLCP and opposing cell contraction [19]: E. coli and Clostridium botu-
linum derived exotoxins EDIN and C3-transferase ADP-ribosylate and inactivate RhoA,
Clostridium difficile toxin B glycosylates and inactivates RhoA whilst Yersinia spp. pro-
duces toxin Yop T which prevents RhoA from co-localising in the cell membrane with
Rho kinase [47-49]. In contrast, SpA from Staphylococcus aureus and CNF1 from E.
coli promote RhoA/ROK activity [50,51]. Endogenous mediators might also contribute
to Ca2+ desensitisation: nitric oxide, kynurenine and ANP levels are elevated in septic
shock [40,52], potentially promoting protein kinase G (PKG)-dependent disinhibition
of MLCP and Ca2+ desensitisation [10,53,54].
Our findings of impaired response to TxA2 and membrane depolarisation may be of
particular clinical significance for two reasons: Firstly, it is well established that restor-
ation of normal systemic circulatory parameters is not necessarily indicative of restored
regional perfusion, and indeed, ongoing regional ischaemia despite restoration of sys-
temic blood pressure is associated with poor clinical outcome [55-58]. Microvascular
splanchnic perfusion is not only reduced but highly heterogeneous in septic shock even
within areas of uniform metabolic demand [20], indicating a failure of local vasomotor
regulation. Since TxA2 [59] and local VSM membrane potential [60,61] play a key role
in local vasomotor regulation, our evidence that their effectiveness is impaired in late
sepsis and might be restored by MLCP inhibition opens a potentially useful area of
investigation. Secondly, the experimentally observed restoration of α1-adrenergic re-
sponses in vitro may not be borne out in the septic patient because in vivo endogen-
ous vasoconstrictors such as constitutively secreted TxA2 and direct depolarisation
potentiate the response to an α1-adrenergic agonist [62]. The apparently attenuated
response to α1-adrenergic agonists in vivo may reflect diminished response to these
normally synergistic vasopressor pathways.Implications for clinical research and management
Our data, from a murine model, identify the association between MLCP disinhibition
and vasopressor insensitivity in a murine model of sepsis. Future studies relating MLCP
activity and regional blood flow in vivo in large animals and ultimately human sepsis
patients will provide valuable insights into the specific clinical consequences of myosin
phosphatase dysregulation.
Advances in our understanding of the pathobiology of sepsis have characterised sep-
sis as a heterogeneous disease, and optimal therapy will need to be tailored to particular
unique patient/pathogen disease phenotypes [63,64]. Our findings suggest that in cer-
tain patients, excessive MLCP activity could contribute to the pathogenesis of sepsis.
Identifying these patients would allow targeted therapeutic inhibition of MLCP or use
of vasopressors less dependent upon RhoA/ROK signalling. Restoring vascular tone by
directly inhibiting MLCP circumvents receptor downregulation and avoids promoting
injurious increases in cytosolic [Ca2+] [12]. In addition, targeting MLCP-dependent Ca2+
sensitisation could be particularly effective in re-establishing local responsiveness to TxA2
and membrane depolarisation, thereby restoring regulation of regional perfusion [18].
The role of RhoA/ROK-mediated inhibition of MLCP extends beyond vascular
smooth muscle: thrombin, a key mediator of the cross-talk between coagulation and
Reddi et al. Intensive Care Medicine Experimental  (2015) 3:2 Page 13 of 15inflammation in sepsis has, been shown to inactivate MLCP and therefore contraction
in a RhoA-dependent manner in human endothelial cells [65]. Given the prominence
of endothelial dysfunction in sepsis, investigating the role of MLCP disinhibition in the
pathogenesis of increased endothelial permeability is a research priority.
Study limitations
We studied an animal model of sepsis at a single time point, and translating our results
to patients mandates caution. To reflect human sepsis as closely as possible, we used a
CLP model, which has advantages over bacterial inoculum and lipopolysaccharide
models [45], incorporating fluid and antibiotic therapy to recreate haemodynamic and
metabolic phases of treated human polymicrobial sepsis. Mortality in the intervention
arm was 16%, comparable to mortality in human studies of severe sepsis, but approxi-
mately half the mortality rate found amongst patients with septic shock [30]. In
addition, to maintain consistency, we analysed vessels from sacrificed mice rather than
mice dying of their sepsis. For these reasons, our data may be derived from somewhat
healthier animals than typical patients with septic shock.
Conclusions
Mechanisms of pathological vasodilation and vasopressor resistance in septic shock are
diverse. Our observations in a murine caecal ligation and puncture model are consist-
ent with the hypothesis that during sepsis disinhibition of myosin phosphatase pro-
motes insensitivity to certain physiologically important vasoconstrictor mechanisms,
such as thromboxane A2 and membrane depolarisation. Approaches aimed at directly
inhibiting MLCP might prove to be an effective therapeutic strategy to counter the
pathological vasodilatation of septic shock.
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